This doesn't mean the medication has quit
Semaglutide is a medication that mimics the effect of GLP-1, a hormone produced in your gut after you eat, and it has several effects on your body, such as: Stimulating insulin secretion and lowering blood sugar levels Slowing down gastric emptying and reducing food intake Increasing energy expenditure and fat-burning Reducing appetite and hunger Enhancing satiety and fullness Semaglutide was originally approved by the FDA as a treatment for type 2 diabetes, and in 2021, it was approved for chronic weight management in adults
31 for Wegovy, Zepbound, Saxenda, Qsymia, Phentermine and Contrave, affecting coverage of those drugs for weight-loss purposes
Understanding their efficacy and mechanisms provides new treatment options for this rare condition and offers evidence for genetically specific personalized weight management
Please ensure you read the patient information leaflet (PIL) provided with your medication before starting treatment